Correlation Between Boule Diagnostics and Prostatype Genomics
Can any of the company-specific risk be diversified away by investing in both Boule Diagnostics and Prostatype Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Boule Diagnostics and Prostatype Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Boule Diagnostics AB and Prostatype Genomics AB, you can compare the effects of market volatilities on Boule Diagnostics and Prostatype Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Boule Diagnostics with a short position of Prostatype Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Boule Diagnostics and Prostatype Genomics.
Diversification Opportunities for Boule Diagnostics and Prostatype Genomics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Boule and Prostatype is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Boule Diagnostics AB and Prostatype Genomics AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prostatype Genomics and Boule Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Boule Diagnostics AB are associated (or correlated) with Prostatype Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prostatype Genomics has no effect on the direction of Boule Diagnostics i.e., Boule Diagnostics and Prostatype Genomics go up and down completely randomly.
Pair Corralation between Boule Diagnostics and Prostatype Genomics
If you would invest 1,000.00 in Boule Diagnostics AB on January 22, 2025 and sell it today you would lose (130.00) from holding Boule Diagnostics AB or give up 13.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Boule Diagnostics AB vs. Prostatype Genomics AB
Performance |
| Timeline |
| Boule Diagnostics |
| Prostatype Genomics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Boule Diagnostics and Prostatype Genomics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Boule Diagnostics and Prostatype Genomics
The main advantage of trading using opposite Boule Diagnostics and Prostatype Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Boule Diagnostics position performs unexpectedly, Prostatype Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prostatype Genomics will offset losses from the drop in Prostatype Genomics' long position.| Boule Diagnostics vs. CellaVision AB | Boule Diagnostics vs. Biotage AB | Boule Diagnostics vs. BioGaia AB | Boule Diagnostics vs. C Rad AB |
| Prostatype Genomics vs. Sprint Bioscience AB | Prostatype Genomics vs. Stayble Therapeutics AB | Prostatype Genomics vs. iZafe Group AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |